GENE ONLINE|News &
Opinion
Blog

RNA
Deals Orna Therapeutics
Orna Therapeutics Secures Multi-Billion RNA Deal With Merck After $221 Million Series B
2022-08-17
Special 2022 Single Cell Sequencing
Single Cell Sequencing – the Current Players
2022-08-04
R&D RNA
Life Began with RNA Theory Gets Renewed Support
2022-05-20
Special ASGCT
RNA Therapeutics Beyond Vaccines
2022-05-19
Feature JPM
JPM22 Highlights: Amgen Sees Potential in Arrakis, Freenome Gets Boosted by Roche Again
2022-01-12
IPO Hong Kong
RNAi Player Sirnaomics Squeezes in $50 Million IPO in Hong Kong
2022-01-03
China Series A FundingCDMO
China’s Innoforce Bags $157 Million to Boost Cell, Gene and RNA CDMO Services
2021-12-10
Special RNA
Scientists Engineer RNA Switches for Targeted Delivery of Gene Therapy and RNA Therapeutics
2021-11-07
Interviews RNA Editing
Current Challenges and Future Opportunities of Artificial RNA Editing – An Interview with Professor Toshifumi Tsukahara
2021-08-26
Delivery System
Scientists Unveil Novel Protein That Delivers Molecular Medicines to Human Cells
2021-08-25
Technology RNA
Laronde Launches to Disrupt the Industry with Programmable Circular RNA Therapies
2021-05-15
Technology oRNA
Orna Therapeutics Brings to Market New Therapy to Treat Cancer and Other Diseases
2021-02-26
JPM Healthcare Conference: Shape, Korro, and Ionis Present Advances in RNA Therapeutics
2021-01-18
Technology CRISPR
Locanabio Raises $100M to Advance CRISPR-Mediated RNA-Targeting Therapies
2020-12-18
Technology RNA Sequencing
Proximity RNA Sequencing: Breaking New Grounds in Spatial Transcriptomics
2020-06-28
1 2
LATEST
Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS
2023-03-24
Moderna Injects $76 Million To Kickstart Lipid Nanoparticle Delivery Partnership With Generation Bio
2023-03-24
Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi
2023-03-23
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
2023-03-23
Biohaven Licenses TYK2/JAK1 Dual Inhibitor From China’s Highlight In $970 Million Pact
2023-03-23
FDA Extends Approval Of Regeneron’s Evkeeza For Inherited High Cholesterol
2023-03-23
Launching an Innovative Product, PlaClin-M, for Safe Environments in the Pandemic Era.
2023-03-23
READ MORE
EVENT
2023-03-28
Reuters Events: Pharma USA 2023
Philadelphia, USA
2023-04-24
Cell & Gene Therapy Summit 2023
Brussels, Belgium
2023-04-28
Boston Chinese Investment Club 2023 Biotech Pitch Competition
Boston, USA
2023-11-16
3rd INTERNATIONAL CONFERENCE ON NUTRITION AND HEALTHCARE
Dubai, UAE
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top